TABLE 3.
Study (year) [ref.] | Age range years | Study groups n | Exacerbation parameter(s) | Data for exacerbations by specified parameter, for each study group |
Exacerbations reported in ≤6 months prior to study entry | ||||
Bateman et al. (2012) [25] | ≥12 | 97, 100, 110, 95, 102, 94 | Pts with ≥1 exacerbation in last 6 months | 18%, 19%, 16%, 25%, 17%, 21% |
McIvor et al. (2009) [22]# | ≥6 | 534 | Patients with any exacerbation in 6 weeks prior to study entry | 51.7% |
Skoner et al. (2005) [57] | 2–5 | 58, 51, 52, 50 | No. of exacerbations in last 30 days | Mean: 1.8, 1.3, 1.5, 1.2 Median: 0,1,0, 0 |
Pts with ≥1 exacerbation in last 30 days | 48.3%, 52.9%, 48.1%, 36.7% | |||
Woodcock et al. (2002) [59] | 18–65 | 86, 86 | Mean no. daytime asthma attacks in 7-day run-in | 0.25, 0.18 |
Mean no. night-time asthma attacks in 7-day run-in | 0.10, 0.10 | |||
Exacerbations reported in 12 months/1 year prior to study entry | ||||
Bateman et al. (2018) [26] | 12–83 | 2089, 2087 | Pts with 1 severe exacerbation in last 12 months | 17.5%, 17.3% |
Pts with ≥1 severe exacerbations in last 12 months | 22%, 21.9% | |||
Pts with ≥2 severe exacerbations in last 12 months | 4.5%, 4.7% | |||
Ding and Small (2017) [49] | ≥12 | 524, 591 | Pts with 1 exacerbation in last 12 months | 9.0%, 13.1% |
Pts with ≥3 exacerbations in last 12 months | 3.4%, 1.9% | |||
Mean (sd) no. of moderate-to-severe exacerbations in last 12 months | 0.2 (0.6)¶ | |||
Mean (sd) no. of exacerbations treated in ED or hospital in last 12 months | 0.1 (0.4), 0.1 (0.3) | |||
Mean (sd) no. of exacerbations treated with OCS, antibiotics, ED or hospital admission in last 12 months+ | 0.1 (0.5), 0.2 (0.6) | |||
Pts with 1 exacerbation treated with OCS, antibiotics, ED or hospital admission in last 12 months+ | 5.8%, 10.8% | |||
Pts with ≥3 exacerbations treated with OCS, antibiotics, ED or hospital admission in last 12 months+ | 1.0%, 1.5% | |||
Giraud et al. (2006) [54] | ≥18 | 94 | Pts hospitalised for asthma in previous 12 months | 4.3% |
Herjavecz et al. (1999) [55] | 17–67 | 90, 91 | Time since last exacerbation | 12.5 months, 13.0 months |
Lai et al. (2003) [61] | Mean 7.4–40.5 | 1709, 633 | Pts with hospital admissions in last year | 7.3%, 15.4% |
Pts with any hospital ED/unscheduled emergency visit in the last year | 33.1%, 41.3% | |||
Martinez et al. (2011) [36] | 5–18 | 71, 72, 71,74 | Mean no. hospital visits for asthma in last 1 year | 0.3, 0.3, 0.2, 0.2 |
O’Byrne et al. (2018) [38] | ≥12 | 1277, 1277,1282 | Pts with ≥1 severe exacerbation in last 12 months | 20.0%, 20.1%, 18.8% |
Peters et al. (2007) [56] | ≥6 | 166, 165, 169 | Pts with ≥1 urgent visit for asthma in last 1 year | 30.7%, 35.8%, 35.5% |
Robertson et al. (2007) [21]§ | 2–14 | 97, 105 | Median no. of ED attendances for asthma in last 1 year | 1, 1 |
Median no. of hospital admissions for asthma in last 1 year | 1, 1 | |||
Soyer et al. (2009) [60] | 6–18 | 522 | Mean (sd) no. of unscheduled visits per patient | 1.2 (0.2) |
Mean (sd) no. of ED visits per patient | 0.6 (0.05) | |||
Verbene et al. (1996) [58] | 7–16 | 30 | Pts hospitalised for asthma in last 1 year | 0% |
All studies were randomised controlled trials except Giraud et al. [54], McIvor et al. [22], Ding and Small [49], Lai et al. [61] and Soyer et al. [60]. pts: patients; ED: emergency department; OCS: oral corticosteroids; no.: number. # Study included patients with a history of exacerbations (time frame not specified); ¶ n=1076; + time frame not specified in Results section of [49] although Methods section suggests 12-month timeframe; §: Study included only patients with a history of 3–6 exacerbations (hospitalisation or ED visit or general practitioner visits) in the 12 months prior to enrolment/screening.